Skip to main content
OpenTrials
Completed

NCT Number: NCT06579118

The Impact of Laughter Yoga on Symptom Management and Quality of Life in Postmenopausal Women

This study aimed to assess the impact of laughter yoga intervention on symptomatology and quality of life among postmenopausal women.The research was conducted in a randomized controlled experimental design.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

45 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ayşe Aydın

Yakutiye, Erzurum, 25000, Turkey (Türkiye)

About this study

The population of the research consisted of menopausal women who applied to the Gynecology Polyclinic of Atatürk University Health Research and Application Center between 25.08.2023 and 15.12.2023. To determine the sample size of the study, a priori power analysis was performed in the G* Power 3.1.9.7 program. Based on the medium effect size (0.5), the alpha value was determined as 5% and the theoretical power was determined as 95%, and the minimum sample size was determined as 64. The sample of the study consisted of 128 women, 64 experimental and 64 control, who met the research criteria and agreed to participate in the research. However, since 8 people in the experimental group could not continue laughter yoga, the study was completed with 120 women.

Criteria for inclusion in the study

  • Entering natural menopause,
  • Being over 45 years old,
  • Being at least a primary school graduate (in order to be able to fill out the forms),
  • Agreeing to participate in the research voluntarily,
  • Not having any hearing or vision problems (in order to be able to perform the sessions),
  • No diagnosed psychiatric disease,
  • Knowing Turkish,
  • Having a smart mobile phone
  • Being open to communication and cooperation.

Exclusion criteria

from the study

  • Not continuing with laughter yoga sessions.

Data were collected using the "Personal Information Form," "Menopause Rating Scale," and "Menopause-Specific Quality of Life Scale." Laughter yoga was used as an intervention tool in the research.Participants in the experimental group underwent laughter yoga sessions twice weekly for four weeks, totaling eight sessions.

The data were collected by the researcher through a face-to-face interview in a suitable empty room at Atatürk University Health Research and Application Center Gynecology Polyclinic. In order to enable women to answer the questions comfortably, each woman was interviewed alone in a separate room in the relevant outpatient clinic. Application of the questionnaire and scales took an average of 10-15 minutes for each woman. Before starting the research, women were informed about the purpose, method, rights and responsibilities of the research.

Process steps experimental group

  • Written consent was obtained from menopausal women who agreed to participate in the study.
  • 10 minutes before starting the laughter yoga, women in menopause were asked to fill out the "Personal Information Form", "Menopause Rating Scale" and "Menopause-Specific Quality of Life Scale" in order to determine their descriptive characteristics.
  • A total of 8 sessions of laughter yoga were applied for 4 weeks, 2 sessions per week. The first session lasted 45 minutes, all other sessions lasted an average of 30 minutes. In the first session, laughter yoga, its history, benefits, breathing techniques, laughter yoga exercises were mentioned before the exercises, and in the following sessions, reminders were made and the session ended with laughter yoga exercises and breathing exercises.
  • After 4 weeks, the process was completed by having women in menopause fill out the "Menopause Rating Scale" and the "Menopause-Specific Quality of Life Scale".

control group

  • Written consent was obtained from pregnant women who agreed to participate in the study.
  • In order to determine the descriptive characteristics of menopausal women, they were asked to fill out the "Personal Information Form", "Menopause Symptoms Evaluation Scale" and "Menopause-Specific Quality of Life Scale".
  • After 4 weeks, the process was completed by having women in menopause fill out the "Menopause Rating Scale" and "Menopause-Specific Quality of Life Scale".

Data analysis included Skewness and Kurtosis values, frequency and percentage distributions, Chi-square tests, Independent Samples t-test, Paired Samples t-test, Mann-Whitney U test, Wilcoxon signed-rank test, and regression analysis. All ethical principles were adhered to throughout the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Entering natural menopause,
  • Being over 45 years old,
  • Being at least a primary school graduate (in order to be able to fill out the forms),
  • Agreeing to participate in the research voluntarily,
  • Not having any hearing or vision problems (in order to be able to perform the sessions),
  • No diagnosed psychiatric disease,
  • Knowing Turkish,
  • Having a smart mobile phone
  • Being open to communication and cooperation.

Exclusion criteria

  • Not continuing with laughter yoga sessions.

Treatment and study plan

laughter yoga

Other

The women in the experimental group were given laughter yoga sessions by the researcher.

Primary outcomes

  1. Personal Information Form

    Time frame: 5 months

    It consists of 10 questions (age, gender, education level, marital status, income status, etc.) prepared by the researcher in line with the literature.

  2. Menopause Rating Scale

    Time frame: 5 months

    The scale, which includes a total of 11 items including menopausal complaints, consists of 3 sub-dimensions. These sub-dimensions are 1-Somatic complaints sub-dimension (items 1,2,3,11), 2-Psychological complaints sub-dimension (items 4,5,6,7), 3-Urogenital complaints sub-dimension (8,9, Article 10). The scale is a 5-point Likert type and each statement is scored as 0: None, 1: Mild, 2: Moderate, 3: Severe and 4: Very severe. The total score of the scale is calculated based on the scores given for each item. The minimum score that can be obtained from the scale is 0, while the maximum score is 44. An increase in the total score obtained from the scale, on the one hand, indicates an increase in the severity of the complaints experienced, and on the other hand, indicates that the quality of life is negatively affected.

  3. Menopause-Specific Quality of Life Scale

    Time frame: 5 months

    It is a Likert type scale containing 29 questions. It consists of four subdomains: vasomotor domain (questions 1-3), psychosocial domain (questions 4-10), physical domain (questions 11-26) and sexual domain (questions 27-29). The complaints that women have experienced in the last month are questioned and the answers to the questions are "yes" or "no". In MÖYÖS, each subdomain score is ranked from 0 to 6. A score of "0" indicates that there are no problems with the issue. A score of "1" indicates that the problem exists and is experienced, but it is not disturbing at all, and scores between "2-6" indicate the severity and increasing degrees of the existing problem. The lowest score that can be obtained from the total of the scale is "0" and the highest score (29X6) is 154. However, evaluation is not made based on the total score.

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Aug 30, 2024
Registry last updated
Dec 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.